Bensydamin Geiser: Uses, Dosage & Side Effects

A benzydamine oral rinse solution for pain relief and anti-inflammatory treatment of the mouth and throat

Rx NSAID – Indazole
Active Ingredient
Benzydamine hydrochloride
Available Forms
Oral rinse solution
Strength
1.5 mg/ml
Brand Name
Bensydamin Geiser

Bensydamin Geiser is a prescription oral rinse solution containing benzydamine hydrochloride at a concentration of 1.5 mg/ml. Benzydamine is an indazole-derived non-steroidal anti-inflammatory drug (NSAID) with local analgesic and anaesthetic properties. It is primarily used for the symptomatic relief of pain and inflammation affecting the mouth and throat, including pharyngitis, mouth ulcers, oral mucositis from radiation or chemotherapy, gingivitis, and post-dental procedure soreness. Unlike conventional oral NSAIDs, benzydamine acts locally with minimal systemic absorption, providing rapid pain relief within minutes of application while maintaining a favourable safety profile.

Quick Facts: Bensydamin Geiser

Active Ingredient
Benzydamine HCl
Drug Class
NSAID (Indazole)
Route
Oromucosal Rinse
Common Uses
Mouth & Throat Pain
Strength
1.5 mg/ml
Prescription Status
Rx (Prescription)

Key Takeaways

  • Benzydamine provides rapid local pain relief: When used as an oral rinse, benzydamine begins working within 2–5 minutes, offering effective short-term relief for sore throats, mouth ulcers, and oral inflammation without the systemic side effects of oral painkillers.
  • Do not swallow the solution: Bensydamin Geiser is designed for topical use only. Rinse or gargle for approximately 30 seconds, then spit the solution out completely.
  • Dilute if stinging occurs: Some patients experience temporary numbness or a stinging sensation when using the undiluted solution. This is normal and can be managed by diluting the rinse with an equal volume of warm water.
  • Particularly valuable for oral mucositis: Benzydamine oral rinse is recommended by international oncology guidelines (MASCC/ISOO) for the prevention and treatment of oral mucositis in patients receiving radiation therapy for head and neck cancers.
  • Minimal drug interactions: Because benzydamine acts locally with very low systemic absorption, clinically significant drug interactions are rare. However, always inform your doctor or dentist about all medications you are using.

What Is Bensydamin Geiser and What Is It Used For?

Bensydamin Geiser is a benzydamine hydrochloride oral rinse solution (1.5 mg/ml) used for the relief of painful inflammatory conditions of the mouth and throat. It provides local anti-inflammatory, analgesic, and mild anaesthetic effects when used as a mouthwash or gargle.

Benzydamine is a unique member of the NSAID family. Unlike familiar NSAIDs such as ibuprofen, naproxen, or diclofenac, which are primarily COX inhibitors, benzydamine belongs to the indazole class of anti-inflammatory agents. It was first synthesised in Italy in the 1960s and has since been used extensively across Europe, Asia, and South America for the management of localised pain and inflammation in the oral cavity and pharynx.

The mechanism of action of benzydamine differs fundamentally from that of traditional NSAIDs. While it does exhibit some weak COX-inhibitory activity, its primary anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines, specifically tumour necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β). Benzydamine also stabilises cell membranes, reduces oxidative damage, and possesses local anaesthetic properties by interfering with sodium channels in nerve fibres. This combination of effects provides rapid and effective pain relief at the site of application.

When applied as an oral rinse, benzydamine is absorbed through the oral mucosa and accumulates preferentially in inflamed tissues. This selectivity is due to the increased blood flow and altered pH that characterise inflamed areas, which enhance the local uptake and retention of the drug. Systemic absorption is minimal – only about 10% of the topically applied dose reaches the systemic circulation – which means that benzydamine oral rinse is associated with a much lower risk of the gastrointestinal, cardiovascular, and renal side effects that can occur with systemic NSAID use.

Approved Indications

Bensydamin Geiser oral rinse is indicated for the symptomatic treatment of painful inflammatory conditions of the oropharynx, including:

  • Pharyngitis and sore throat: Relief of pain and inflammation associated with viral or bacterial infections of the throat, tonsillitis, and upper respiratory tract infections
  • Oral mucositis: Prevention and treatment of radiation-induced and chemotherapy-induced mucositis, a particularly debilitating condition that affects up to 80% of patients receiving radiotherapy for head and neck cancers
  • Aphthous stomatitis: Treatment of painful mouth ulcers (canker sores), including recurrent aphthous ulceration
  • Gingivitis and periodontal disease: Relief of gum inflammation and pain, including as an adjunct to dental scaling and root planing
  • Post-dental procedure pain: Management of pain and swelling following dental extractions, implant placement, periodontal surgery, and other oral surgical procedures
  • Denture-related irritation: Relief of sore spots and inflammation caused by poorly fitting dentures or orthodontic appliances
Clinical significance in oncology

The Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines specifically recommend benzydamine oral rinse for the prevention of oral mucositis in patients receiving moderate-dose radiation therapy (up to 50 Gy) for head and neck cancers. This is based on high-quality evidence from randomised controlled trials demonstrating a significant reduction in the severity and incidence of mucositis.

How Benzydamine Works in Detail

The pharmacological profile of benzydamine is multifaceted and distinguishes it from other topical oral treatments. At the molecular level, benzydamine exerts its effects through several complementary mechanisms:

  • Cytokine inhibition: Benzydamine suppresses the production and release of TNF-α and IL-1β, two key pro-inflammatory mediators that drive the inflammatory cascade in conditions such as mucositis and pharyngitis
  • Membrane stabilisation: The drug integrates into cell membranes, reducing their fluidity and permeability, which limits the release of inflammatory mediators from damaged cells
  • Local anaesthesia: Benzydamine blocks voltage-gated sodium channels in sensory nerve fibres, providing rapid numbing of the affected area and reducing pain perception
  • Antimicrobial activity: At therapeutic concentrations, benzydamine demonstrates activity against several common oral pathogens, including Candida albicans and various bacterial species, which may contribute to its clinical effectiveness in treating oral infections
  • Antioxidant properties: Benzydamine scavenges reactive oxygen species (ROS), helping to protect oral mucosal tissues from oxidative damage

After application as an oral rinse, peak local tissue concentrations are achieved within minutes. The analgesic effect is typically felt within 2–5 minutes and lasts for approximately 1–2 hours. The anti-inflammatory effect builds over several days of regular use, with maximum benefit usually seen within 3–5 days of initiating treatment.

What Should You Know Before Taking Bensydamin Geiser?

Before using Bensydamin Geiser oral rinse, check that you are not allergic to benzydamine or any of the excipients in the formulation. This product is designed for topical use in the mouth and throat only and should not be swallowed. Special precautions apply to children, pregnant women, and breastfeeding mothers.

While benzydamine oral rinse has a well-established safety profile due to its predominantly local action, it is important to be aware of certain contraindications and precautions before starting treatment. As with all medications, the decision to use Bensydamin Geiser should involve a thorough consideration of your individual circumstances, medical history, and current medication regimen.

Contraindications

Do not use Bensydamin Geiser if:

  • Known hypersensitivity: You are allergic to benzydamine hydrochloride or any of the other ingredients (excipients) listed in the product information
  • History of aspirin-sensitive asthma: Patients who have experienced bronchospasm, urticaria, or rhinitis triggered by aspirin or other NSAIDs should exercise caution, although cross-reactivity with benzydamine is rare due to its different mechanism of action

Warnings and Precautions

Talk to your doctor, dentist, or pharmacist before using Bensydamin Geiser if any of the following apply:

  • Asthma or a history of bronchospasm: Although extremely rare with topical benzydamine, NSAID-sensitive asthma patients should use the product with caution and be aware of potential respiratory symptoms
  • Persistent oral ulceration: If mouth ulcers do not improve within 7 days of treatment, or if new ulcers continue to appear, seek medical or dental advice. Persistent oral ulceration may indicate an underlying condition requiring further investigation
  • Difficulty gargling: Children or individuals who cannot reliably gargle and spit should not use the oral rinse, as repeated swallowing of the solution is not intended
  • Open wounds or large mucosal lesions: While benzydamine is generally well tolerated on damaged mucosa, extensive open wounds in the oral cavity may increase systemic absorption
Important: Duration of use

Bensydamin Geiser is intended for short-term symptomatic relief. If symptoms persist for more than 7 days without improvement, consult a healthcare professional. Prolonged use without medical supervision is not recommended, as the underlying cause of oral pain or inflammation may require specific treatment.

Pregnancy and Breastfeeding

The safety of benzydamine oral rinse during pregnancy and breastfeeding has not been established through large-scale clinical trials. However, because systemic absorption from topical oral application is minimal (approximately 10%), the risk to the fetus or nursing infant is considered low. Nevertheless, the following precautions apply:

  • Pregnancy: Use during pregnancy should be limited to situations where the expected benefit to the mother outweighs the potential risk. Consult your doctor or midwife before using Bensydamin Geiser if you are pregnant or planning to become pregnant
  • Breastfeeding: It is not known whether benzydamine or its metabolites pass into breast milk in clinically significant amounts following topical oral use. Given the low systemic absorption, the risk is considered negligible, but consultation with a healthcare provider is recommended
  • Fertility: There are no data suggesting that topical benzydamine affects fertility in either men or women

Use in Children

Bensydamin Geiser oral rinse is generally recommended for adults and adolescents aged 12 years and older. For younger children, the use of oral rinse solutions can be problematic because they may not be able to gargle and spit reliably, increasing the risk of accidental swallowing. If a healthcare professional determines that a child under 12 may benefit from benzydamine rinse, the solution should be diluted with an equal volume of water and used under direct adult supervision.

How Does Bensydamin Geiser Interact with Other Drugs?

Because benzydamine acts primarily locally in the mouth and throat with minimal systemic absorption, clinically significant drug interactions are very rare. No major drug interactions have been documented with benzydamine oral rinse in standard clinical use.

One of the key clinical advantages of benzydamine oral rinse over systemic anti-inflammatory medications is its favourable interaction profile. When used as directed (rinse and spit), only a small fraction of the applied dose reaches the systemic circulation, making pharmacokinetic interactions with other medications unlikely. This is particularly important for patients who are taking multiple medications, such as those undergoing cancer treatment or elderly patients with polypharmacy.

Despite the low risk, patients should always inform their healthcare provider about all medications they are currently using, including prescription drugs, over-the-counter medicines, herbal supplements, and other oral hygiene products. The following considerations are relevant:

Potential Considerations with Other Medications
Drug / Category Interaction Type Clinical Significance Recommendation
Other oral rinses (chlorhexidine, hydrogen peroxide) Potential local interaction Low Separate use by at least 30 minutes to avoid dilution or inactivation of either product
Systemic NSAIDs (ibuprofen, naproxen) Theoretical additive effect Very low Concurrent use is generally safe; the systemic absorption of topical benzydamine is too low to produce meaningful additive effects
Anticoagulants (warfarin, heparin, DOACs) No documented interaction Negligible Safe to use concurrently; no dose adjustment needed
Chemotherapy agents No documented interaction Negligible Commonly used alongside chemotherapy regimens for mucositis prevention
Alcohol-containing products Potential mucosal irritation Low Avoid alcohol-based mouthwashes simultaneously; may increase stinging sensation

Alcohol Content

Some formulations of benzydamine oral rinse contain ethanol as an excipient. Patients who are avoiding alcohol for medical, religious, or personal reasons should check the specific product formulation. Alcohol-free benzydamine rinse formulations are available in some markets. The alcohol content, when present, is generally small (around 10%) and exposure is brief since the rinse is spat out, but patients on disulfiram or metronidazole therapy should be aware of the potential for a minor interaction if small amounts are inadvertently swallowed.

What Is the Correct Dosage of Bensydamin Geiser?

The standard dose for adults and children over 12 years is 15 ml of the oral rinse solution (1.5 mg/ml), used to rinse or gargle for approximately 30 seconds, then spat out. This can be repeated every 1.5 to 3 hours as needed for symptom relief.

The dosage of Bensydamin Geiser oral rinse is based on the standardised volume of solution used per application rather than a weight-based calculation. The 1.5 mg/ml concentration has been optimised to provide effective local concentrations of benzydamine in the oral mucosa and pharynx when used in the recommended volume.

Adults and Adolescents (Over 12 Years)

Standard Dosing

  • Volume per dose: 15 ml (one tablespoon or measured with the provided dosing cup)
  • Method: Rinse the mouth or gargle for approximately 30 seconds
  • Frequency: Every 1.5 to 3 hours as needed
  • Duration: Use for up to 7 days. If symptoms persist, consult a healthcare professional
  • Important: Spit out the solution after rinsing. Do not swallow

Children (Under 12 Years)

Paediatric Dosing (Under Medical Supervision)

  • Not generally recommended: Children under 12 should only use benzydamine oral rinse under direct medical or dental supervision
  • Ability to gargle: The child must be able to gargle reliably and spit out the solution without swallowing
  • Dilution: If prescribed, dilute the rinse with an equal volume of warm water (i.e., mix 7.5 ml solution with 7.5 ml water)
  • Supervision: An adult must be present during every use to ensure the solution is not swallowed

Elderly Patients

Elderly Dosing

  • No dose adjustment needed: The standard adult dose applies to elderly patients
  • Dry mouth considerations: Elderly patients with xerostomia (dry mouth) may experience more pronounced stinging; dilution with water can help
  • Denture wearers: Remove dentures before rinsing for optimal contact with affected areas. Wait at least 15 minutes before reinserting dentures
Dosage Summary by Patient Group
Patient Group Dose Frequency Special Instructions
Adults & adolescents (>12 years) 15 ml undiluted Every 1.5–3 hours Rinse or gargle 30 seconds, spit out
Children (<12 years) 15 ml diluted 1:1 with water As directed by doctor Must be able to gargle and spit; adult supervision required
Elderly 15 ml (dilute if stinging occurs) Every 1.5–3 hours Remove dentures before use
Oral mucositis (oncology) 15 ml undiluted Every 2–3 hours during waking hours Start before radiotherapy begins; continue throughout treatment course

How to Use Bensydamin Geiser Correctly

To get the best results from Bensydamin Geiser oral rinse, follow these step-by-step instructions:

  1. Measure the dose: Pour 15 ml of the solution into the provided measuring cup. Do not estimate – use the cup for accuracy
  2. Rinse or gargle: Take the solution into your mouth and either swish it around the entire oral cavity (for mouth conditions) or tilt your head back and gargle (for throat conditions). Maintain this for approximately 30 seconds
  3. Spit out completely: After rinsing, spit the entire volume of solution out into a sink. Do not swallow any of the rinse
  4. Do not eat or drink immediately: Wait at least 15–30 minutes after rinsing before eating, drinking, or using other oral products to allow the benzydamine to be absorbed into the mucosa
  5. Replace the cap: Securely close the bottle after each use to prevent contamination and evaporation

Missed Dose

Bensydamin Geiser is used on an as-needed basis for symptom relief rather than on a strict schedule. There is no concept of a “missed dose” in the traditional sense. Simply use the rinse when you next experience pain or discomfort. Do not use a double volume to compensate for a dose that was not taken.

Overdose

Overdose from topical oral use of benzydamine is extremely unlikely when the product is used as directed (rinse and spit). However, if a large volume of the solution is accidentally or intentionally ingested, the following symptoms may occur:

  • Nausea and vomiting
  • Abdominal discomfort
  • In rare cases of very large ingestion: agitation, hallucinations, tremors, or seizures (due to benzydamine’s effects on the central nervous system at high systemic doses)
In case of accidental ingestion

If a significant amount of Bensydamin Geiser is swallowed, particularly by a child, contact your local poison control centre or seek emergency medical advice immediately. Bring the product packaging with you. Treatment is supportive and symptomatic, as there is no specific antidote for benzydamine overdose.

What Are the Side Effects of Bensydamin Geiser?

Benzydamine oral rinse is generally well tolerated. The most common side effects are local in nature, including temporary numbness or tingling in the mouth, a stinging sensation, and dry mouth. These are usually mild and resolve quickly. Serious side effects are very rare.

The side effect profile of benzydamine oral rinse is favourable compared to systemic NSAIDs, primarily because of its topical route of administration and minimal systemic absorption. Most adverse effects are localised to the oral cavity and are self-limiting. Clinical trials and post-marketing surveillance data have established the following frequency categories for adverse reactions:

Common

Affects 1 to 10 in every 100 patients

  • Numbness or tingling sensation in the mouth (paraesthesia)
  • Stinging or burning sensation upon application
  • Dry mouth or altered sensation of thirst

Uncommon

Affects 1 to 10 in every 1,000 patients

  • Nausea (if small amounts are inadvertently swallowed)
  • Oral irritation or dryness of the mucous membranes
  • Taste disturbance (dysgeusia)
  • Mild headache

Rare

Affects fewer than 1 in 1,000 patients

  • Allergic reactions: skin rash, itching, or urticaria (hives)
  • Photosensitivity (increased sensitivity to sunlight)
  • Laryngospasm or throat tightness

Very Rare / Frequency Not Known

Reported from post-marketing surveillance

  • Anaphylaxis or severe allergic reaction (extremely rare)
  • Angioedema (swelling of the face, lips, tongue, or throat)

Managing Common Side Effects

The most frequently reported side effect – oral numbness or stinging – is a direct result of benzydamine’s local anaesthetic properties and is not harmful. It typically resolves within 10–15 minutes of spitting out the rinse. If the stinging sensation is bothersome, the most effective remedy is to dilute the solution with an equal volume of warm water before use. This reduces the local concentration without significantly compromising the therapeutic effect.

Dry mouth is another commonly reported effect that usually improves with continued use as the oral mucosa adapts to the product. Sipping water between rinses can help maintain oral comfort. If taste disturbance occurs, it is typically mild and temporary, resolving within hours of the last application.

When to Seek Medical Attention

While serious side effects from benzydamine oral rinse are extremely rare, you should stop using the product and seek immediate medical attention if you experience:

  • Signs of a severe allergic reaction: difficulty breathing, swelling of the face, lips, tongue, or throat, widespread skin rash with hives, or feeling faint
  • Severe or worsening oral pain that does not respond to treatment
  • Persistent oral ulceration or white patches that have not improved after 7 days of use
  • Unexpected bleeding from the gums or mouth
Reporting side effects

If you experience any side effects not listed here, or if any of the listed effects become severe, please report them to your healthcare provider. You can also report suspected adverse reactions to your national pharmacovigilance authority. Reporting helps to improve the safety information available for this medicine.

How Should You Store Bensydamin Geiser?

Store Bensydamin Geiser at room temperature (below 25°C) in the original packaging, protected from light and moisture. Keep out of reach of children. Do not use after the expiry date printed on the packaging.

Proper storage of your medication ensures that it remains effective and safe throughout its shelf life. Benzydamine oral rinse is a liquid formulation that can be affected by extremes of temperature, light exposure, and contamination. Follow these storage guidelines:

  • Temperature: Store at room temperature, ideally below 25°C (77°F). Do not refrigerate or freeze the solution
  • Light protection: Keep the bottle in its original outer carton when not in use to protect from light, which can degrade the active ingredient over time
  • Moisture: Store in a dry place. Avoid keeping the bottle in the bathroom, where humidity and temperature fluctuations are common
  • Seal tightly: Always replace the cap securely after each use to prevent evaporation of the solvent and contamination of the remaining solution
  • Keep out of reach of children: Store the product where children cannot access it. Accidental ingestion by children can lead to adverse effects
  • Expiry date: Do not use Bensydamin Geiser after the expiry date (EXP) stated on the carton and bottle label. The expiry date refers to the last day of that month
  • After opening: Once opened, the solution should be used within the timeframe specified in the product information (typically within 6 months of opening, or as stated on the label)

Do not dispose of the medication via household waste or wastewater. Ask your pharmacist about the proper way to dispose of medicines you no longer need or that have expired. These measures help protect the environment.

What Does Bensydamin Geiser Contain?

Bensydamin Geiser contains the active substance benzydamine hydrochloride at a concentration of 1.5 mg/ml. It also contains various excipients that serve as solvents, preservatives, flavouring agents, and pH adjusters to ensure the stability, palatability, and effectiveness of the formulation.

Active Ingredient

Each millilitre of Bensydamin Geiser oral rinse contains:

  • Benzydamine hydrochloride: 1.5 mg (equivalent to approximately 1.34 mg of benzydamine base)

Benzydamine hydrochloride is the water-soluble salt form of benzydamine (chemical name: 1-benzyl-3-(3-dimethylaminopropoxy)-1H-indazole hydrochloride). The hydrochloride salt form is used because it provides superior aqueous solubility compared to the free base, ensuring a stable and homogeneous oral rinse solution.

Excipients (Inactive Ingredients)

The excipients in benzydamine oral rinse formulations typically include:

  • Ethanol (if present): Serves as a co-solvent to maintain benzydamine in solution and has mild antimicrobial properties
  • Glycerol: A humectant that helps maintain moisture in the oral mucosa and contributes to the mouthfeel of the solution
  • Methyl parahydroxybenzoate (methylparaben): A preservative that prevents microbial contamination of the product
  • Flavouring agents: Typically mint or menthol-based flavours to improve palatability
  • Saccharin sodium: An artificial sweetener to mask the bitter taste of benzydamine
  • Polysorbate 20: An emulsifier that helps distribute the active ingredient evenly throughout the solution
  • Sodium bicarbonate or citric acid: pH adjusters that maintain the solution at an optimal pH for stability and mucosal compatibility
  • Purified water: The primary solvent and vehicle for the formulation
Allergy information

If you have known allergies to any preservatives (particularly parabens), artificial sweeteners, or alcohol, check the complete list of excipients in the package leaflet or consult your pharmacist before use. The exact composition may vary slightly between different manufacturers and markets.

Frequently Asked Questions About Bensydamin Geiser

Bensydamin Geiser is a benzydamine oral rinse solution used for the relief of pain and inflammation in the mouth and throat. It is commonly prescribed for sore throat (pharyngitis), mouth ulcers, gum inflammation (gingivitis), oral mucositis caused by radiation therapy or chemotherapy, and pain following dental procedures. The solution works by providing local anti-inflammatory, analgesic, and mild anaesthetic effects directly at the site of application.

Measure 15 ml of the solution using the provided measuring cup. Take the solution into your mouth and either swish it around the entire oral cavity or tilt your head back to gargle for approximately 30 seconds. Then spit the solution out completely – do not swallow it. You can repeat this every 1.5 to 3 hours as needed. If the solution causes stinging, dilute it with an equal volume of warm water before use.

No, Bensydamin Geiser oral rinse is not intended to be swallowed. It is designed for topical use in the mouth and throat only. After rinsing or gargling, always spit the solution out. While accidentally swallowing small amounts during gargling is unlikely to cause significant harm, intentional or repeated swallowing should be avoided. If a large amount is swallowed, contact a healthcare professional or poison control centre.

Yes, benzydamine oral rinse is specifically recommended by international oncology guidelines (MASCC/ISOO) for the prevention and treatment of oral mucositis in patients undergoing radiation therapy for head and neck cancers. It has been shown in randomised controlled trials to reduce the severity of mucositis and improve patient quality of life during treatment. It does not interact with chemotherapy drugs and can be used safely alongside cancer treatments. Always follow your oncologist’s instructions regarding dosage and timing.

The numbness and stinging sensation are direct effects of benzydamine’s pharmacological properties. Benzydamine has local anaesthetic activity, which causes the temporary numbing feeling. The stinging is related to the drug’s interaction with nerve endings in the oral mucosa and may be more pronounced when the mucosa is already inflamed or damaged. Both effects are harmless and typically last only 10–15 minutes. Diluting the solution with an equal volume of warm water before use significantly reduces the stinging without compromising effectiveness.

Benzydamine oral rinse provides rapid local pain relief, typically within 2 to 5 minutes of application. This is due to its combined local anaesthetic and anti-inflammatory properties. The pain-relieving effect generally lasts for 1 to 2 hours, after which the rinse can be reapplied. The full anti-inflammatory benefit builds over several days of regular use, with optimal results usually achieved within 3 to 5 days of consistent treatment.

References & Sources

This article is based on the following peer-reviewed sources and international medical guidelines:

  1. Karavana Hizarcioglu SY, et al. “Benzydamine hydrochloride buccal bioadhesive gels designed for oral ulcers: preparation, rheological, textural, mucoadhesive and release properties.” Pharmaceutical Development and Technology. 2009;14(6):623-631.
  2. Lalla RV, Bowen J, Barasch A, et al. “MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy.” Cancer. 2014;120(10):1453-1461. doi:10.1002/cncr.28592
  3. Epstein JB, Silverman S, Paggiarino DA, et al. “Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.” Cancer. 2001;92(4):875-885.
  4. Quane PA, Graham GG, Ziegler JB. “Pharmacology of benzydamine.” Inflammopharmacology. 1998;6(2):95-107. doi:10.1007/s10787-998-0026-0
  5. European Medicines Agency (EMA). “Benzydamine-containing medicinal products for oromucosal use.” Assessment Report. EMA/HMPC/2015.
  6. British National Formulary (BNF). “Benzydamine hydrochloride.” National Institute for Health and Care Excellence (NICE). Accessed 2026.
  7. Nicolatou-Galitis O, Sarri T, Bowen J, et al. “Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.” Supportive Care in Cancer. 2013;21(11):3179-3189. doi:10.1007/s00520-013-1847-y
  8. WHO Model List of Essential Medicines. 23rd Edition. World Health Organization. 2023.
  9. Cheng KKF, Yuen JKT. “A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer.” Cancer Nursing. 2006;29(5):423-430.
  10. Sironi M, Massimiliano L, Transidico P, et al. “Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist.” International Journal of Clinical Practice. 2006;60(7):867-872.

Editorial Team

This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed physicians, pharmacists, and medical writers with expertise in clinical pharmacology and oral medicine.

Medical Writing

Content researched and written by qualified medical writers following iMedic’s evidence-based editorial standards. All medical claims are referenced to peer-reviewed literature and international guidelines.

Medical Review

Independently reviewed by the iMedic Medical Review Board. All clinical information verified against current BNF, EMA, and MASCC/ISOO guidelines. Last medical review: .

Editorial Policy: iMedic is committed to providing accurate, evidence-based medical information that is free from commercial influence. We do not accept pharmaceutical industry funding or advertising. All content follows the GRADE evidence framework and is regularly updated to reflect the latest clinical evidence. Read our full editorial standards.